SCHEMBL4740790

SCHEMBL4740790

COC(=O)C(CC=C(C)C)C(=O)OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41
GRIK1 P39086 1/20 0.37
GRIK2 Q13002 1/20 0.37
ALOX15 P16050 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
PTGES O14684 1/20 0.35
ALDH1A1 P00352 3/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MME P08473 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
MGAM O43451 1/20 0.32
GAA P10253 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11811520 0.91 FNTA (0.39) FNTAFNTBGRIK1GRIK2ALOX15
SCHEMBL12088542 0.80 ALOX15 (0.39) FNTAFNTBGRIK1GRIK2ALOX15
SCHEMBL10655821 0.80 ALOX15 (0.39) FNTAFNTBGRIK1GRIK2ALOX15
SCHEMBL9190299 0.80 ALDH1A1 (0.42) FNTAFNTBGRIK1GRIK2ALOX15
SCHEMBL17296120 0.78 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1MEN1KMT2AMME
SCHEMBL4420430 0.76 SMN1; SMN2 (0.39) SMN1; SMN2ALDH1A1MEN1KMT2AMME
SCHEMBL8134708 0.75 GRIK1 (0.47) FNTAFNTBGRIK1GRIK2ALOX15
SCHEMBL3092195 0.75 FNTA (0.63) FNTAFNTBGRIK1GRIK2ALDH1A1
SCHEMBL22466380 0.75 FNTA (0.66) FNTAFNTBALOX15ALDH1A1MEN1
SCHEMBL17230821 0.75 FNTA (0.66) FNTAFNTBALOX15ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250391519-A1 CHEMICAL SYNTHESIS PLATFORM UNIV GLASGOW COURT (GB) 2025-12-25 US disclosed
EP-4548355-A1 CHEMICAL SYNTHESIS PLATFORM The University Court Of The University Of Glasgow (GB) 2025-05-07 EP disclosed
WO-2024003151-A1 CHEMICAL SYNTHESIS PLATFORM THE UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) 2024-01-04 WO disclosed
WO-2008101683-A2 Fe(-II) CATALYST SYSTEMS Universität Dortmund (DE) 2008-08-28 WO disclosed
US-4904815-A PHENOLS WITH ESTER, ACID OR AMIDE FUNCTIONAL GROUPS, STABILIZERS FOR AQUEOUS OR ORGANIC SYSTEMS CIBA-GEIGY AG (CH) 1990-02-27 US disclosed
EP-0106799-B1 PHENOLS AND THEIR PREPARATION CIBA-GEIGY AG (CH) 1986-03-19 EP disclosed
EP-0106799-A1 Phenols and their preparation CIBA-GEIGY AG (CH) 1984-04-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250391519-A1 CHEMICAL SYNTHESIS PLATFORM SET, CBS, COASY FNTA 281/4885FNTB 380/4885GRIK1 1307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.